Hiew Tze Ning, Solomos Marina A, Kafle Prapti, Polyzois Hector, Zemlyanov Dmitry Y, Punia Ashish, Smith Daniel, Schenck Luke, Taylor Lynne S
Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.
Oral Formulation Sciences, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
J Pharm Sci. 2025 Jan;114(1):289-303. doi: 10.1016/j.xphs.2024.09.020. Epub 2024 Sep 28.
One of the limitations with an amorphous solid dispersion (ASD) formulation strategy is low drug loading. Hydrophobic drugs have poor wettability and require a substantial amount of polymer to stabilize the amorphous drug and facilitate release. Using grazoprevir and hypromellose acetate succinate as model drug and polymer, respectively, the interplay between particle surface composition, particle wettability, and release performance was investigated. A hierarchical particle approach was used where the surfaces of high drug loading ASDs generated by either solvent evaporation or co-precipitation were further modified with a secondary excipient (i.e., polymer or wetting agent). The surface-modified particles were characterized for drug release, wettability, morphology, and surface composition using two-stage dissolution studies, contact angle measurements, scanning electron microscopy, and X-ray photoelectron spectroscopy, respectively. Despite surface modification with hydrophilic polymers, the hierarchical particles did not consistently exhibit good release performance. Contact angle measurements showed that the secondary excipient had a profound impact on particle wettability. Particles with good wettability showed improved drug release relative to particles that did not wet well, even with similar drug loadings. These observations underscore the intricate interplay between particle wettability and performance in amorphous dispersion formulations and illustrate a promising hierarchical particle approach to formulate high drug loading amorphous dispersions with improved dissolution performance.
无定形固体分散体(ASD)制剂策略的局限性之一是药物载量低。疏水性药物的润湿性差,需要大量聚合物来稳定无定形药物并促进释放。分别以格拉瑞韦和醋酸羟丙甲纤维素琥珀酸酯作为模型药物和聚合物,研究了颗粒表面组成、颗粒润湿性和释放性能之间的相互作用。采用了一种分级颗粒方法,通过溶剂蒸发或共沉淀生成的高载药量ASD的表面,用第二种辅料(即聚合物或润湿剂)进一步修饰。分别使用两阶段溶出研究、接触角测量、扫描电子显微镜和X射线光电子能谱对表面改性颗粒的药物释放、润湿性、形态和表面组成进行了表征。尽管用亲水性聚合物进行了表面改性,但分级颗粒并未始终表现出良好的释放性能。接触角测量表明,第二种辅料对颗粒润湿性有深远影响。润湿性良好的颗粒相对于润湿性不佳的颗粒,即使载药量相似,药物释放也有所改善。这些观察结果强调了颗粒润湿性与无定形分散体制剂性能之间的复杂相互作用,并说明了一种有前景的分级颗粒方法,用于制备具有改善溶出性能的高载药量无定形分散体。